Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for hospitalized patients with COVID-19
IRCT20111224008507N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoints: Clinical improvement, Duration of hospital stay and 2 more. Started Feb 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20111224008507N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111224008507N5.